Optimized cementitious immobilization of simulated cesium and barium radionuclides in borate waste solution by natural zeolite additives. [PDF]
Iklaga G +10 more
europepmc +1 more source
Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management. [PDF]
Shaikh MS +7 more
europepmc +1 more source
The relationship between yttrium-90 glass microspheres specific activity, particle density and treatment outcomes in HCC and mCRC. [PDF]
Lam MGEH +5 more
europepmc +1 more source
Complications and outcomes of radioligand therapy in patients with neuroendocrine neoplasms depending on the baseline glomerular filtration rate. [PDF]
Durma AD +6 more
europepmc +1 more source
Safety and Feasibility of Interventional Hybrid Fluoroscopy and Nuclear Imaging in the Work-up Procedure of Hepatic Radioembolization. [PDF]
Dietze MMA +8 more
europepmc +1 more source
Are survival outcomes dependent on the tumour dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-centre study. [PDF]
Topcuoglu OM, Orhan T, Gormez A, Alan N.
europepmc +1 more source
Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging. [PDF]
Zeimpekis KG +8 more
europepmc +1 more source
Related searches:
The Radiopharmaceutical Chemistry of the Radioisotopes of Lutetium and Yttrium
Radiopharmaceutical Chemistry, 2019When harnessing radiometals for medical applications, both the aqueous chemistry of the metal ion (e.g. its coordination number, Lewis acidity, solvent activation, pKa) and the properties of the chelator (e.g. donor atoms, denticity, charge, polarity) should be carefully considered to ensure the stable in vivo sequestration of the radionuclide.
Elaheh Khozeimeh Sarbisheh +1 more
openaire +2 more sources

